Physician profile
Steven Goldstein
NPI 1629019179
$1,421.00
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $174 · 2021: $357 · 2022: $265 · 2023: $68.77 · 2024: $20.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $294.16 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $275.45 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $146.09 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $116.98 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $108.43 | 2019-2022 | |
| Boston Scientific Corporation | $79.92 | 2019-2020 | |
| Tactile Systems Technology INC | $56.18 | 2022 | |
| Medtronic Vascular, INC. | $54.19 | 2019-2020 | |
| Amgen INC. | $53.06 | 2019-2020 | |
| Abiomed | $39.32 | 2022 | |
| Sanofi-Aventis U.S. LLC | $35.22 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.85 | 2021-2022 | |
| Pfizer INC. | $28.10 | 2019-2023 | |
| Medtronic, INC. | $23.42 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $20.63 | 2023 | Arcalyst |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $17.35 | 2022 | |
| Daiichi Sankyo INC. | $13.94 | 2023 | Injectafer |
| Abbott Laboratories | $12.56 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $12.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.